Hypertension and fatty liver: guilty by association?

Research output: Contribution to journalArticle

Standard

Hypertension and fatty liver: guilty by association? / Brookes, Matthew; Cooper, Brian.

In: Journal of Human Hypertension, Vol. 21, No. 4, 01.04.2007, p. 264-70.

Research output: Contribution to journalArticle

Harvard

APA

Vancouver

Author

Bibtex

@article{e1874c9b39ec43958cd8aede884139b5,
title = "Hypertension and fatty liver: guilty by association?",
abstract = "Essential hypertension is associated with the metabolic syndrome, insulin resistance and the development of fatty liver. Fatty liver disease is a spectrum of liver diseases ranging from simple hepatic steatosis through steato-hepatitis to cirrhosis and hepatoma. The purpose of this review is to discuss the evidence for an association between essential hypertension and non-alcoholic fatty liver disease, and to consider the diagnosis and management of non-alcoholic fatty liver disease. We conclude that it is important to consider the diagnosis of fatty liver disease in hypertensive patients, to measure the liver function tests at diagnosis and not to ignore minor elevations of serum aminotransferases. Hypertensive patients with raised liver enzymes should be referred for further assessment, particularly if risk factors for progressive liver disease, such as obesity and diabetes, are present.",
author = "Matthew Brookes and Brian Cooper",
year = "2007",
month = apr,
day = "1",
doi = "10.1038/sj.jhh.1002148",
language = "English",
volume = "21",
pages = "264--70",
journal = "Journal of Human Hypertension",
issn = "0950-9240",
publisher = "Nature Publishing Group",
number = "4",

}

RIS

TY - JOUR

T1 - Hypertension and fatty liver: guilty by association?

AU - Brookes, Matthew

AU - Cooper, Brian

PY - 2007/4/1

Y1 - 2007/4/1

N2 - Essential hypertension is associated with the metabolic syndrome, insulin resistance and the development of fatty liver. Fatty liver disease is a spectrum of liver diseases ranging from simple hepatic steatosis through steato-hepatitis to cirrhosis and hepatoma. The purpose of this review is to discuss the evidence for an association between essential hypertension and non-alcoholic fatty liver disease, and to consider the diagnosis and management of non-alcoholic fatty liver disease. We conclude that it is important to consider the diagnosis of fatty liver disease in hypertensive patients, to measure the liver function tests at diagnosis and not to ignore minor elevations of serum aminotransferases. Hypertensive patients with raised liver enzymes should be referred for further assessment, particularly if risk factors for progressive liver disease, such as obesity and diabetes, are present.

AB - Essential hypertension is associated with the metabolic syndrome, insulin resistance and the development of fatty liver. Fatty liver disease is a spectrum of liver diseases ranging from simple hepatic steatosis through steato-hepatitis to cirrhosis and hepatoma. The purpose of this review is to discuss the evidence for an association between essential hypertension and non-alcoholic fatty liver disease, and to consider the diagnosis and management of non-alcoholic fatty liver disease. We conclude that it is important to consider the diagnosis of fatty liver disease in hypertensive patients, to measure the liver function tests at diagnosis and not to ignore minor elevations of serum aminotransferases. Hypertensive patients with raised liver enzymes should be referred for further assessment, particularly if risk factors for progressive liver disease, such as obesity and diabetes, are present.

U2 - 10.1038/sj.jhh.1002148

DO - 10.1038/sj.jhh.1002148

M3 - Article

C2 - 17273155

VL - 21

SP - 264

EP - 270

JO - Journal of Human Hypertension

JF - Journal of Human Hypertension

SN - 0950-9240

IS - 4

ER -